Get the app
US › Healthcare

Surrozen Inc (SRZN)

US · Healthcare · Biotechnology

$23.44-6.50%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$5.0M
Revenue YoY
+408.6%
Net profit
$50.2M
Profit YoY
+26.2%
EPS
$-0.41
EPS estimate
$-1.34
Net margin
1,003.5%

EPS came in at -0.41 against a street estimate of -1.34 — a beat of 69.4%.

Key statistics

Market cap
$276.3M
Forward P/E
0.0
P/B
2.50
Book value
$-18.60
EPS (TTM)
$-39.08
52-week high
$37.83
52-week low
$11.39
50-day MA
$23.61
200-day MA
$24.71
Beta
0.47

Analyst view

Analysts rate Surrozen Inc a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $48.40.

Shareholding

Insiders
3.14%
Institutions
115.98%

Largest institutional holders

FundStake
TCG Crossover Management, LLC12.53%
Boxer Capital Management, LLC9.41%
Kalehua Capital Management LLC6.55%
Millennium Management LLC5.81%
Point72 Asset Management, L.P.5.65%
VR Adviser, LLC5.38%
StemPoint Capital LP5.13%
Perceptive Advisors LLC4.29%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Surrozen Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.